| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.1M | — | +113.3% |
| Cost of Revenue | $2.1M | — | +110.1% |
| Gross Profit | $9.9M | — | +114.0% |
| R&D Expense | $1.7M | — | +25.0% |
| SG&A Expense | $25.2M | — | +85.2% |
| Operating Income | -$16.9M | — | -64.4% |
| Pre-tax Income | -$17.7M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $55.7M | +65.9% | — |
| Accounts Receivable | $4.9M | +9.4% | — |
| Inventory | $6.0M | +10.8% | — |
| Current Assets | $71.7M | +54.7% | — |
| Total Assets | $73.6M | +52.9% | — |
| Current Liabilities | $11.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.7M | — | -82.3% |
| Capital Expenditures | $42K | — | +82.6% |
| Investing Cash Flow | -$42K | — | -82.6% |
| Financing Cash Flow | $39.9M | — | +23.1% |
| Free Cash Flow | -$17.8M | — | -82.3% |
| -66.5% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$17.7M | — | -66.5% |
| EPS (Basic) | -$19.30 | — | -48.8% |
| EPS (Diluted) | -$19.30 | — | -48.8% |
| +16.0% |
| — |
| Total Liabilities | $61.6M | +221.5% | — |
| Stockholders' Equity | -$167.7M | -11.3% | -44.3% |